← Leaderboards
Frank J Raucci
Virginia Commonwealth University
$859,692
Attributed
$859,692
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $148.7K · FY2017–25$200K$150K$100K$50K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$859,692 · 2
By mechanism
K08$741,945 · 1
F32$117,747 · 1
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Sarah Spiegel$20,919,449
- Paul Dent$11,860,656
- Jose Francisco Huizar$2,594,731
- Leslie S Satin$12,285,413
- Robert Delorenzo$15,322,261
Others in their field
Other Emerging Leaders on “Foundations”
- Valerie Koch · University Corporation For Atmospheric Res$265,601,376
- Lisa Garcia Bedolla · University Of California-Berkeley$175,927,128
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- John E West · University Of Texas At Austin$131,399,667
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Peter K Fritschel · California Institute Of Technology$78,820,000
Research focus
FoundationsHeart RhythmDilated CardiomyopathyFibrosisGenerationsHeart FailureCoculture TechniquesDefectDuchenne Muscular DystrophyFibroblastsFunctional DisorderCardiacArrhythmiaHeart DiseasesCardiac Myocytes18 Year OldCardiovascular DiseasesCoronary FibrosisCause Of DeathBoysDystrophinCell MotilityCalciumHypoxia
Grant awards (7)
Targeting Pannexin 1 as a Novel Mechanism for Arrhythmia and Fibrosis in Duchenne Cardiomyopathy$148,052
K08 · FY2025 · HL · contact PI
Targeting Pannexin 1 as a Novel Mechanism for Arrhythmia and Fibrosis in Duchenne Cardiomyopathy$148,214
K08 · FY2024 · HL · contact PI
Targeting Pannexin 1 as a Novel Mechanism for Arrhythmia and Fibrosis in Duchenne Cardiomyopathy$148,405
K08 · FY2023 · HL · contact PI
Targeting Pannexin 1 as a Novel Mechanism for Arrhythmia and Fibrosis in Duchenne Cardiomyopathy$148,560
K08 · FY2022 · HL · contact PI
Targeting Pannexin 1 as a Novel Mechanism for Arrhythmia and Fibrosis in Duchenne Cardiomyopathy$148,714
K08 · FY2021 · HL · contact PI
Role of Pannexin Channels in Arrhythmogenesis and Cardiac Fibrosis in Models of Duchenne Muscular Dystrophy$52,497
F32 · FY2018 · HL · contact PI
Role of Pannexin Channels in Arrhythmogenesis and Cardiac Fibrosis in Models of Duchenne Muscular Dystrophy$65,250
F32 · FY2017 · HL · contact PI